GEN Exclusives

More »

Best of the Web

More »
Jun 15, 2012 (Vol. 32, No. 12)

JANE

URL:www.biosemantics.org/jane
  • Multiple search options
  • Search not perfect, can’t organize results by publication date

In the “publish or perish” world of academic research, investigators must acquire an intuition for appropriate journals to which to submit their manuscripts. One must balance considerations such as “impact factor” and “whether or not I have a chance in you-know-where of getting my manuscript accepted.” To assist researchers with the guesswork, The Biosemantics Group has created JANE, the Journal/Author Name Estimator. Users enter their manuscript title or abstract into the search box, and then JANE searches Medline for the best corresponding journals—that is, the journals that have recently published papers on similar topics. Alternatively, users can search for authors or articles related to their query. Even if one does not intend to use JANE for their manuscripts, the site is still a good resource to find articles or authors publishing work related to one’s own research. Rather than searching by title or abstract, users can opt to search by keyword.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?